Does Wellcare Cover Januvia?
The verdict
Covered on most plans
Yes — Wellcare (Centene) covers Januvia for type 2 diabetes on its 2026 Medicare Part D plans (Value Script and Classic PDPs) and Medicaid managed-care plans. As a Part D sponsor, Wellcare is legally required to carry Januvia at the IRA negotiated Maximum Fair Price of $113 per 30-day supply, effective January 1, 2026 — a 79% reduction from the prior list price of approximately $527. On Wellcare Part D, prior authorization is generally low for Januvia on Medicare. On Wellcare Managed Medicaid, a metformin-first step therapy is often required. Generic sitagliptin (Sandoz, launched May 2026) is now available as a lower-cost alternative.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Wellcare using your member ID.
Key facts
The 2026 IRA Maximum Fair Price for Januvia is $113 per 30-day supply — a 79% reduction from the prior list price of approximately $527; all Wellcare Part D plans must apply this price, effective January 1, 2026.
CMS Medicare Drug Price Negotiation Program, 2026 MFP
Generic sitagliptin (Januvia's generic) launched May 2026 (Sandoz), bringing cash prices from approximately $700 for the brand to approximately $110 with a coupon — a cost lever available across all plan types.
Sandoz press release, May 26, 2026; GoodRx pricing data
Wellcare's 2026 Part D plans carry a $615 annual deductible and a $2,100 out-of-pocket cap. Wellcare's 5-6 tier structure means confirming Januvia's specific tier on your plan is essential before your first fill.
CMS Final CY 2026 Part D Redesign Program Instructions; Wellcare plan benefit documents
Medicare vs. commercial coverage
Whether Wellcare covers Januvia depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Januvia is covered on Wellcare's 2026 Medicare Part D plans — Value Script and Classic PDPs — typically as a Tier 3 preferred brand. Prior authorization and step therapy are generally low on Medicare for Januvia, which is less managed than the SGLT2 class in this channel. As a Part D sponsor, Wellcare must apply the IRA negotiated Maximum Fair Price of $113 per 30-day supply effective January 1, 2026 — a 79% reduction from the prior list price of approximately $527. Wellcare's Part D cost architecture: a $615 annual deductible (the maximum under the 2026 CMS Part D redesign), then Tier 3 cost-share in the initial coverage phase, with a $2,100 annual out-of-pocket cap. Wellcare's 5–6 tier structure (Tier 1 preferred generic $0 at preferred pharmacy; Tier 3 preferred brand; a distinct Tier 6 for select chronic-condition drugs) means you should confirm which tier Januvia sits on your specific Wellcare plan. Note: generic sitagliptin (launched May 2026) may be placed on a lower tier than the brand — check the Wellcare formulary for both. LIS/Extra Help enrollees pay $0–$12.65 per month. Medicare beneficiaries cannot use the Merck $5 copay card. Note: do not confuse Januvia with Janumet (sitagliptin/metformin combination), which is a separate product with a 2027 IRA MFP timeline.
Commercial / Employer
Group & marketplace plans
Wellcare's commercial and ACA footprints are limited relative to its Medicare Part D and Medicaid MCO operations. Where Wellcare commercial or ACA plans are offered, Januvia is covered for type 2 diabetes. Metformin-first step therapy is common for DPP-4 inhibitors on commercial plans; verify your specific plan formulary. Wellcare Managed Medicaid covers Januvia; metformin-first step therapy and prior authorization are common per state Preferred Drug Lists, with typical cost-share of $0–$10. Generic sitagliptin (launched May 2026) is available and may be placed on a lower formulary tier. Brand Januvia retails at approximately $696–$721, while generic sitagliptin is approximately $110 with a coupon (pharmacy-variable estimates). The Merck $5 copay card is for commercially insured patients not enrolled in government programs; Wellcare Part D and Medicaid enrollees cannot use it.
The 3 boxes you must tick to get approved
Commercial plans that will consider Januvia require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Januvia actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Brand Januvia: approximately $696–$721 per 30-day supply at retail pharmacy (pharmacy-variable estimate). Generic sitagliptin: approximately $110 with a coupon (pharmacy-variable estimate — launched May 2026).
List price with no coverage — before any manufacturer savings card.
With coverage
Medicare Part D (Wellcare Value Script/Classic): $615 annual deductible; then Tier 3 cost-share; IRA Maximum Fair Price $113 per 30-day supply effective January 1, 2026; $2,100 annual out-of-pocket cap; LIS/Extra Help $0–$12.65 per month. Medicaid: $0–$10 typical. Commercial: Merck $5 copay card (commercially insured only, not government-insured). All figures are estimates — verify with your specific Wellcare plan.
Typical monthly copay once prior authorization is approved.
All dollar figures are estimates. Your actual cost depends on your Wellcare plan's tier structure, deductible status, and benefit phase. The $615 deductible must be met before cost-sharing applies in the initial coverage phase. The MFP of $113 is a payer-side ceiling — your copay depends on whether your plan uses a fixed copay or coinsurance. Generic sitagliptin (launched May 2026) may be on a lower tier and offer significant cost savings. Confirm your cost-share on the Wellcare formulary. Medicare beneficiaries cannot use the Merck $5 copay card. Do not confuse Januvia with Janumet (combination product with a 2027 IRA timeline).
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Januvia and generic sitagliptin on the Wellcare plan formulary
Visit Wellcare.com and use the drug pricing or formulary search for your 2026 plan (Value Script, Classic PDP, or Medicaid plan). Search for both 'Januvia' and 'sitagliptin' to find the tier for each. Generic sitagliptin (launched May 2026) may be on a lower tier than brand Januvia. Confirm any prior authorization or step-therapy requirements and whether your plan uses a fixed copay or coinsurance.
- 2
Ask your prescriber to document metformin history if on Medicaid or commercial
If you are on Wellcare Managed Medicaid or a Wellcare commercial plan, a metformin-first step-therapy requirement is common for DPP-4 inhibitors like Januvia. Ask your prescriber to document prior metformin use (dose, duration, and reason for stopping or contraindication) to satisfy the step-therapy requirement. This documentation should resolve most coverage requests without a lengthy appeals process.
- 3
Call Wellcare member services to verify your deductible status, tier, and step-therapy
Call the number on the back of your Wellcare ID card. Ask: (1) Has my $615 deductible been met? (2) Which tier is Januvia or generic sitagliptin on my plan? (3) Is prior authorization or step therapy required? (4) Does a quantity limit apply? Have your plan ID and drug dosage ready to speed up the lookup.
Options if Wellcare won't cover Januvia
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic sitagliptin
Generic sitagliptin (Januvia's generic, launched May 2026 by Sandoz) is now available. Brand Januvia retails at approximately $696–$721, while generic sitagliptin is approximately $110 with a coupon. Generics are typically placed on a lower formulary tier, potentially on Wellcare's Tier 1 or Tier 2, significantly reducing your cost-share. Discuss with your prescriber whether the generic is appropriate.
Jardiance (empagliflozin)
An SGLT2 inhibitor for T2D, heart failure, and CKD. The 2026 IRA negotiated price is $197 per 30-day supply. On Wellcare Part D, PA is essentially zero for Jardiance; Wellcare Managed Medicaid commonly requires metformin-first. No generic currently available for Jardiance.
Farxiga (dapagliflozin) or generic dapagliflozin
Another SGLT2 inhibitor for T2D, heart failure, and CKD. Generic dapagliflozin is available. The 2026 IRA negotiated price for Farxiga is $178.50 per 30-day supply. Discuss clinical appropriateness with your prescriber.
Metformin (generic)
First-line oral diabetes medication; Tier 1 at approximately $4 per month cash price. Wellcare places generic metformin on Tier 1 ($0 at preferred pharmacy in Part D). If Managed Medicaid step therapy requires metformin first, this is the prerequisite drug.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Yes — Wellcare (Centene) covers Januvia for type 2 diabetes on its 2026 Medicare Part D plans (Value Script and Classic PDPs) and Medicaid managed-care plans, typically as a Tier 3 preferred brand. Prior authorization is generally low on Medicare. On Wellcare Managed Medicaid, metformin-first step therapy is often required. The 2026 IRA negotiated Maximum Fair Price is $113 per 30-day supply. Generic sitagliptin launched in May 2026.
CMS negotiated a Januvia Maximum Fair Price of $113 per 30-day supply, effective January 1, 2026 — a 79% reduction from the prior list price of approximately $527, the largest percentage discount among IRA Round 1 drugs. All Wellcare Part D plans must apply this price. Your actual copay depends on whether your plan uses a fixed copay or coinsurance, and on the $615 deductible status. The $2,100 annual cap protects against the highest out-of-pocket costs.
Most Wellcare 2026 Part D plans carry the maximum allowable deductible of $615. Until you satisfy this deductible, you pay the full negotiated cost for non-exempt tiers — including Januvia. After the deductible, your Tier 3 cost-share applies, and the $2,100 annual cap limits total exposure. Check whether generic sitagliptin (launched May 2026) is on a lower tier that might be deductible-exempt or have a lower cost-share. Confirm your deductible status with Wellcare member services.
Yes, in most states. Wellcare Managed Medicaid commonly applies a metformin-first step therapy for DPP-4 inhibitors like Januvia: your prescriber must document that you have tried metformin at the maximum tolerated dose, or that metformin is contraindicated (for example, due to severe renal impairment). Once metformin use is documented, the coverage process is typically straightforward. Verify the specific requirement on your state's Preferred Drug List or with Wellcare Medicaid member services.
Generic sitagliptin (Januvia's generic, launched May 2026 by Sandoz) should now be available on Wellcare formularies, likely on a lower tier than brand Januvia. Brand Januvia retails at approximately $696–$721, while generic sitagliptin is approximately $110 with a coupon. Check the Wellcare drug formulary for generic sitagliptin's tier. Ask your prescriber whether switching to the generic is clinically appropriate for your situation.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Wellcare before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.